NCT05482555

Brief Summary

A single-center prospective study. Patients undergoing surgery for acute type A aortic dissection with femoral arterial cannulation between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden are eligible. Femoral cannulation was performed either with surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania). Data regarding preoperative clinical characteristics and operative details were obtained by medical records review.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 29, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 1, 2022

Completed
Last Updated

January 4, 2023

Status Verified

January 1, 2023

Enrollment Period

5.4 years

First QC Date

July 29, 2022

Last Update Submit

January 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Femoral access site complication

    Seroma, wound infection, or nerve injury

    During the first 8 weeks after surgery

Secondary Outcomes (1)

  • Femoral artery complication

    During the first 3 years after surgery

Study Arms (2)

Intervention/treatment Surgical cut-down and arterial puncture under direct vision

Surgical cut-down and arterial puncture under direct vision.

Procedure: Surgical cut-down and arterial puncture under direct vision

Percutaneous arteriotomy closed with closure device

Percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania).

Procedure: Percutaneous arteriotomy closed using a plug-based arteriotomy closure device

Interventions

Percutaneous arteriotomy closed using a plug-based arteriotomy closure device (MANTA, Essential Medical Inc., Malvern, Pennsylvania).

Percutaneous arteriotomy closed with closure device

Surgical cut-down and arterial puncture under direct vision.

Intervention/treatment Surgical cut-down and arterial puncture under direct vision

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patientes operated for acute type A aortic dissection with femoral arterial cannulation between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden, with use of either surgical cut-down and arterial puncture under direct vision or percutaneously with planned percutaneous arteriotomy closed using a plug-based arteriotomy closure device.

You may qualify if:

  • Operated for acute type A aortic dissection between 2017 and 2022 at the Karolinska University Hospital in Stockholm, Sweden.

You may not qualify if:

  • Non-femoral arterial cannulation
  • Concomitant femoro-femoral bypass
  • Conversion to ECMO with arterial inflow in the previously cannulated femoral artery
  • Death within 30 days from procedure
  • Loss to follow-up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiothoracic Surgery, Karolinska University Hospital

Stockholm, Sweden

Location

MeSH Terms

Conditions

Aortic Dissection

Condition Hierarchy (Ancestors)

Dissection, Blood VesselAneurysmVascular DiseasesCardiovascular DiseasesAcute Aortic SyndromeAortic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 1, 2022

Study Start

January 1, 2017

Primary Completion

June 1, 2022

Study Completion

June 1, 2022

Last Updated

January 4, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Individual participant data not planned to be shared.

Locations